Literature DB >> 34592340

Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.

Mengjie Li1, Tingting Guo2, Jiayi Lin3, Xia Huang4, Qiaodan Ke5, Yujian Wu6, Chunping Fang7, Chenxia Hu8.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: In traditional Chinese medicine, there is a long history that curcuma longa L is used to treat distending pain of chest and belly, arthralgia of shoulder and arm aggravated by cold. Traditional Chinese medicine holds that breast cancer is caused by cold congelation, stagnation of qi and blood stasis. It is usually treated with some pungent and warm Chinese herbs, such as Curcuma longaL and Curcuma zedoaria (Christm.) Rosc, which are effective in promoting blood circulation for removing blood stasis, activating qi-flowing and relieving pain. Curcumin, a polyphenolic compound, is the main pharmacological component extracted from the rhizome of Curcuma longa L. Modern pharmacological studies have found that curcumin has many kinds of pharmacological activities of anti-inflammatory, anti-tumor, anti-angiogenesis, anti-metastasis and anti-multidrug resistance. AIM OF THE STUDY: To explore the mechanism of curcumin and Glioma-associated oncogene homolod-1 (Gli1) on invasion and metastasis of triple negative breast cancer (TNBC) cells through the Hedgehog (Hh)/Gli signaling pathway.
MATERIAL AND METHODS: The effect of curcumin on TNBC cells was detected by colony formation, wound healing and transwell assay. Breast cancer stem cells (BCSCs) were cultured in serum-free medium and its stemness was detected by flow cytometry and subcutaneous xenografted tumor assay. The formation of mammospheres was used to detect the effect of curcumin and GANT61 (Gli inhibitor)on the formation ability of BCSCs. Gli1 overexpressed was conducted in MDA-MB-231 cells by lentivirus vector HBLV-h-Gli1-3xflag-ZsGreen-PURO. RT-qPCR and Western blot were detected the mRNA and protein level of genes of Hh pathway, Epithelial-mesenchymal transition (EMT) and stemness. The nuclear localization and expression of Gli1 was observed by laser confocal microscope scanning. Co-IP was investigated the key genes interacted with Gli1.
RESULTS: The abilities of proliferation, invasion, migration and the formation of mammospheres in TNBC cells were inhibited by curcumin. Furthermore, curcumin reduced the invasion and migration abilities in stable Gli1-overexpressing MDA-MB-231 cell. Moreover, curcumin down-regulated the expression of genes related Hh pathway, EMT and stemness in MDA-MB-231 mammospheres. Observation of laser confocal microscope showed that Gli1 were expressed mainly in nucleus in MDA-MB-231 adherent cells and completely in nucleus in BCSCs, which was significantly reduced in the nucleus and cytoplasm after curcumin treatment. Besides, our results suggested that vimentin was interacted with Gli1.
CONCLUSIONS: Curcumin can inhibit the proliferation and metastasis of TNBC cells, EMT and characteristics of BCSC by Hedgehog/Gli1 pathway.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer stem cells; Curcumin; Gli1; Hedgehog; Triple negative breast cancer

Mesh:

Substances:

Year:  2021        PMID: 34592340     DOI: 10.1016/j.jep.2021.114689

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Authors:  Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 2.  Fate decisions of breast cancer stem cells in cancer progression.

Authors:  Hui Xu; Fengxia Zhang; Xiaokang Gao; Qiwang Zhou; Linhai Zhu
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

3.  Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study.

Authors:  Banafsheh Honarvari; Sara Karimifard; Niyayesh Akhtari; Mehrnoush Mehrarya; Zahra Salehi Moghaddam; Mohammad Javed Ansari; Abduladheem Turki Jalil; Adrián Matencio; Francesco Trotta; Faten Eshrati Yeganeh; Bahareh Farasati Far; Mandana Kazem Arki; Mohammad Reza Naimi-Jamal; Hassan Noorbazargan; Zahra Asghari Lalami; Mohsen Chiani
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

Review 4.  Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review.

Authors:  Zhi-Jun Yang; Si-Yu Huang; Dan-Dan Zhou; Ruo-Gu Xiong; Cai-Ning Zhao; Ai-Ping Fang; Yun-Jian Zhang; Hua-Bin Li; Hui-Lian Zhu
Journal:  Antioxidants (Basel)       Date:  2022-07-28

Review 5.  The Synergistic Effects of Curcumin and Chemotherapeutic Drugs in Inhibiting Metastatic, Invasive and Proliferative Pathways.

Authors:  Maria Younes; Rita Mardirossian; Liza Rizk; Tia Fazlian; Jean Paul Khairallah; Christopher Sleiman; Hassan Y Naim; Sandra Rizk
Journal:  Plants (Basel)       Date:  2022-08-17

6.  The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs.

Authors:  Shu-Ling Chen; Chia-Ying Ho; Wei-Chun Lin; Chao-Wei Lee; Yu-Chun Chen; Jiun-Liang Chen; Hsing-Yu Chen
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.